NEA 16 Amends Stake in Marker Therapeutics
Ticker: MRKR · Form: SC 13D/A · Filed: May 17, 2024 · CIK: 1094038
| Field | Detail |
|---|---|
| Company | Marker Therapeutics, Inc. (MRKR) |
| Form Type | SC 13D/A |
| Filed Date | May 17, 2024 |
| Risk Level | medium |
| Pages | 14 |
| Reading Time | 17 min |
| Key Dollar Amounts | $0.001, $50.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, schedule-13d, beneficial-ownership
TL;DR
NEA 16 just updated their 13D filing for Marker Therapeutics, looks like they're still a major player.
AI Summary
On May 17, 2024, New Enterprise Associates 16, L.P. (NEA 16) filed an amendment to their Schedule 13D concerning Marker Therapeutics, Inc. The filing indicates a change in beneficial ownership, with NEA 16 now holding a significant stake in the company. This filing is an update to previous disclosures regarding their investment in Marker Therapeutics.
Why It Matters
This filing signals a potential shift in the shareholder landscape of Marker Therapeutics, which could influence future strategic decisions or board representation.
Risk Assessment
Risk Level: medium — Changes in beneficial ownership filings can indicate shifts in investor sentiment or strategy, potentially impacting the stock price.
Key Players & Entities
- New Enterprise Associates 16, L.P. (company) — Filing entity
- Marker Therapeutics, Inc. (company) — Subject company
- ALI BEHBAHANI (person) — Group member
- ANTHONY A. FLORENCE, JR. (person) — Group member
- CARMEN CHANG (person) — Group member
- FOREST BASKETT (person) — Group member
- MOHAMAD H. MAKHZOUMI (person) — Group member
- NEA 16 GP, LLC (company) — Group member
- NEA PARTNERS 16, L.P. (company) — Group member
- PAUL WALKER (person) — Group member
FAQ
What is the primary purpose of this SC 13D/A filing?
This filing is an amendment to a Schedule 13D, indicating a change in beneficial ownership of Marker Therapeutics, Inc. by New Enterprise Associates 16, L.P. and its group members.
Who are the key entities involved in this filing?
The key entities are Marker Therapeutics, Inc. (the subject company) and New Enterprise Associates 16, L.P. (the filing entity), along with its group members.
When was this filing submitted?
The filing was submitted on May 17, 2024.
What was Marker Therapeutics, Inc. formerly known as?
Marker Therapeutics, Inc. was formerly known as TAPIMMUNE INC. and GENEMAX CORP.
What is the business address of Marker Therapeutics, Inc.?
The business address of Marker Therapeutics, Inc. is 4551 KENNEDY COMMERCE DR., HOUSTON, TX 77032.
Filing Stats: 4,229 words · 17 min read · ~14 pages · Grade level 8.4 · Accepted 2024-05-17 18:25:14
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti
- $50.00 — le immediately, at an exercise price of $50.00 per share with a five-year term (the &l
Filing Documents
- nea16-marker_18847.htm (SC 13D/A) — 393KB
- 0001072613-24-000515.txt ( ) — 395KB
From the Filing
SC 13D/A 1 nea16-marker_18847.htm NEW ENTERPRISE ASSOCIATES 16, L.P. / MARKER THERAPEUTICS, INC. -- SCHEDULE 13D/A(#2) Schedule 13D UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Marker Therapeutics, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 57055L206 (CUSIP Number) Stephanie Brecher New Enterprise Associates 1954 Greenspring Drive, Suite 600 Timonium, MD 21093 (410) 842-4000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) May 15, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.57055L206 13D Page 2 of 20 Pages 1. NAMES OF REPORTING PERSONS. New Enterprise Associates 16, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) WC 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 0 Shares 8. SHARED VOTING POWER 1,071,428 Shares 9. SOLE DISPOSITIVE POWER 0 Shares 10. SHARED DISPOSITIVE POWER 1,071,428 Shares 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,071,428 Shares 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 12.0% 14. TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.57055L206 13D Page 3 of 20 Pages 1. NAMES OF REPORTING PERSONS. NEA Partners 16, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 0 Shares 8. SHARED VOTING POWER 1,071,428 Shares 9. SOLE DISPOSITIVE POWER 0 Shares 10. SHARED DISPOSITIVE POWER 1,071,428 Shares 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,071,428 Shares 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 12.0% 14. TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.57055L206 13D Page 4 of 20 Pages 1. NAMES OF REPORTING PERSONS. NEA 16 GP, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Liability Company NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 0 Shares 8. SHARED VOTING POWER 1,071,428 Shares 9. SOLE DISPOSITIVE POWER 0 Shares 10. SHARED DISPOSITIVE POWER 1,071,428 Shares 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,071,428 Shares 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 12.0% 14. TYPE OF REPORTING PERSON (see instructions) OO CUSIP No.57055L206 13D Page 5 of 20 Pages 1. NAMES OF REPORTING PERSONS. Forest Baskett 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instruc